Furthermore, analysis of a published clinical dataset (GSE15471) revealed that compared with normal pancreatic tissues, SIRT1 and CUL4B expression increased in pancreatic tumor samples, while FOXO3 and GRHL3 significantly decreased (Fig. S5A). This evidence concerns the gene FOXO3 and pancreatic neoplasm.